Search
European Web Survey on Drugs 2021: Emerging findings in Lebanon
The European Web Survey on Drugs1 collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon. In this period, the populations in many European and...
European Web Survey on Drugs
The European Web Survey on Drugs collected data between March and April 2021 from people who use drugs, aged 18 or older, living in 21 EU and 9 non-EU countries. During this period the populations in many European countries were...
Synthetic cannabinoids in Europe – a review
This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System.
The aim of this report is to strengthen situational awareness of synthetic...
New Benzodiazepines in Europe – A Review
Summary
This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System.
The aims of this report are to strengthen situational awareness of new...
European Drug Report 2021
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these...
Global Drug Survey 2020
Global Drug Survey (GDS) runs the world’s largest survey.
GDS believes that the expertise and experience of people who use alcohol and other drugs can be used to inform the creation of better drug policy.
The GDS 2020 includes data...
Human Rights and People Who Use Drugs in the Mediterranean Region
This publication gives a first overview of the human rights situation of people who use drugs in 17 MedNET countries. MedNET is the Mediterranean network for co-operation on drugs and addictions of the Pompidou Group.
Among the topics...
EMCDDA Technical Report on New Psychoactive Substance
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...
European Drug Report 2020
European Drug Report 2020
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug...
National Drug Strategy Household Survey 2019
Summary
Tobacco, alcohol and illicit drug use can place a heavy burden on individuals, families and society. The health,
social and economic effects are diverse and substantial, and include disease and injury, mental health
conditions...
Alcohol consumption during the COVID-19 period: May 2020
The aim of this paper is to analyse changes in alcohol consumption since the spread of the COVID-19 pandemic.
We show that the frequency of alcohol consumption during COVID-19 is slightly higher for males than it was 2-3 years previously...
Wastewater Analysis and Drugs - A European Multi-City Study
Alcohol, Pregnancy and Infant Health – A Shared Responsibility
"Of all the lifestyle choices we make in conjunction with pregnancy, none are of greater importance to the child’s future health and development than the ones we make in relation to alcohol."
Alcohol, pregnancy and infant health – a...
Noncommunicable Disease Progress Monitor
Noncommunicable diseases are the leading cause of premature death globally.
Every year, 41 million people die from heart attacks, stroke, cancer, chronic respiratory diseases, diabetes or a mental disorder.
Despite the concerning...
What Has Happened Since – 2020 Report
The Nordic Alcohol and Drug Policy Network (NordAN) was established in September 2000 as a network of non-governmental, voluntary organisations. Their aim is to reduce the consumption of alcohol and other drugs and support restrictive...
Drug-Related Hospital Emergency Presentations in Europe: Update from the Euro-DEN Plus Expert Network
Summary
This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe.
Almost 24,000 emergency presentations were recorded at 32 sentinel hospitals over the first 4...
Alcohol, Tobacco & other Drugs in Australia
The consumption of alcohol, tobacco and other drugs is a significant cause of preventable disease and illness in Australia. There is a wide range of data sources available that contribute to our understanding of alcohol, tobacco and...
Harm to Others from Drinking: Patterns in Nine Societies
The adverse impact of alcohol consumption include the negative consequences of drinking on individuals other than the drinkers themselves, including both health and social problems. Alcohol’s harm to others (HTO) is an interactional...
Alcohol and Cancer Risks: A Guide for Health Professionals
Drinking alcohol increases the risk of mouth cancer, pharyngeal (upper throat) cancer, oesophageal (food pipe) cancer, laryngeal (voice box) cancer, breast cancer, bowel cancer and liver cancer.
Having conversations with patients about...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member